BA
RKDA icon

BlackRock Advisors’s Arcadia Biosciences RKDA Stock Holding History

BlackRock Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3
Closed -$6K – 3792
2016
Q1 		$6K Hold
3
– – ﹤0.01% 3651
2015
Q4 		$6K Sell
3
-2
-40% -$5.21K ﹤0.01% 3693
2015
Q3 		$12K Hold
5
– – ﹤0.01% 3625
2015
Q2 		$24K Buy
+5
New +$31.1K ﹤0.01% 3461

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Advisors's RKDA Position: Q2 2016 in Review

BlackRock Advisors sold out of Arcadia Biosciences (RKDA) in Q2 2016, closing a stake of 3 shares — an estimated $6K sold.

BlackRock Advisors first reported a position in RKDA in Q2 2015 and held it in 4 quarters. The position peaked at $24K in Q2 2015. 20 funds tracked by Wall St. Rank hold RKDA as of Q2 2016.

  • BlackRock Advisors reported no remaining Arcadia Biosciences position as of Q2 2016 after selling out during the quarter.
  • BlackRock Advisors sold 3 Arcadia Biosciences shares in Q2 2016, an estimated $6K.
  • BlackRock Advisors first reported a position in Arcadia Biosciences in Q2 2015 and held it in 4 quarters.
  • BlackRock Advisors's Arcadia Biosciences position peaked at $24K in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2016.

Based on BlackRock Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.